Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015 (2015), Article ID 325305, 5 pages
http://dx.doi.org/10.1155/2015/325305
Clinical Study

Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer

1Department of Urology, Social Insurance Funabashi Central Hospital, 6-13-10 Kaijin, Funabashi, Chiba 273-8556, Japan
2Department of Urology, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan
3Department of Pathology, Social Insurance Funabashi Central Hospital, 6-13-10 Kaijin, Funabashi, Chiba 273-8556, Japan
4Department of Pathology, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan

Received 26 September 2014; Revised 31 March 2015; Accepted 31 March 2015

Academic Editor: Ronald M. Bukowski

Copyright © 2015 Tomonori Kato et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Badalament and R. N. Farah, “Treatment of superficial bladder cancer with intravesical chemotherapy,” Seminars in Surgical Oncology, vol. 13, no. 5, pp. 335–341, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Ali-El-Dein, M. El-Baz, A. N. M. Aly, S. Shamaa, and A. Ashamallah, “Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study,” The Journal of Urology, vol. 158, no. 1, pp. 68–74, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Tolley, M. K. B. Parmar, K. M. Grigor et al., “The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of followup,” The Journal of Urology, vol. 155, no. 4, pp. 1233–1238, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Oosterlinck, K. H. Kurth, F. Schroder et al., “A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder,” Journal of Urology, vol. 149, no. 4, pp. 749–752, 1993. View at Google Scholar · View at Scopus
  5. E. Solsona, I. Iborra, J. V. Ricós, J. L. Monrós, J. Casanova, and R. Dumont, “Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up,” Journal of Urology, vol. 161, no. 4, pp. 1120–1123, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Rajala, E. Kaasinen, M. Raitanen, T. Liukkonen, and E. Rintala, “Perioperative single dose instillation of epirubicin or interferon-α after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study—Finnbladder III long-term results,” The Journal of Urology, vol. 168, no. 3, pp. 981–985, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. R. J. Cersosimo and W. K. Hong, “Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue,” Journal of Clinical Oncology, vol. 4, no. 3, pp. 425–439, 1986. View at Google Scholar · View at Scopus
  8. H. Araki, T. Mishina, K. Miyakoda, T. Fujiwara, and T. Kobayashi, “Cytosine arabinoside bladder instillation therapy for bladder tumors,” Tohoku Journal of Experimental Medicine, vol. 136, no. 1, pp. 23–28, 1982. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Akaza, K. H. Kurth, R. Williams et al., “Intravesical chemotherapy and immunotherapy for superficial tumors: basic mechanism of action and future direction,” Urologic Oncology, vol. 4, no. 4-5, pp. 121–129, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Koga, K. Kuroiwa, A. Yamaguchi, Y. Osada, M. Tsuneyoshi, and S. Naito, “A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder,” Journal of Urology, vol. 171, no. 1, pp. 153–157, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Huncharek, J.-F. Geschwind, B. Witherspoon, R. McGarry, and D. Adcock, “Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials,” Journal of Clinical Epidemiology, vol. 53, no. 7, pp. 676–680, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Ali-El-Dein, O. Sarhan, A. Hinev, E.-H. I. Ibrahiem, A. Nabeeh, and M. A. Ghoneim, “Superficial bladder tumours: analysis of prognostic factors and construction of a predictive index,” BJU International, vol. 92, no. 4, pp. 393–399, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Perlis, A. R. Zlotta, J. Beyene, A. Finelli, N. E. Fleshner, and G. S. Kulkarni, “Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review,” European Urology, vol. 64, no. 3, pp. 421–430, 2013. View at Publisher · View at Google Scholar · View at Scopus